Clinical Trial: A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07640217) titled 'A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)' on June 05.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of SYH2068 injection in patients with elevated lipoprotein(a).

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Adult Participants With Elevated Lipoprotein(a)

Intervention: DRUG: SYH2068 Dose 1

Administered by subcutaneous injection.

DRUG: SYH2068 Dose 2

Administered by subcutaneous injection.

DRUG: SYH2068 Dose 3

Administered by subcutaneous injection.

DRUG: Placebo

Administered by subcutaneous injection.

Recruitment Status: N...